Reproducibility of real world evidence studies using clinical practice data to inform regulatory and coverage decisions


31 August 2022 - Studies that generate real world evidence on the effects of medical products through analysis of digital data collected in clinical practice provide key insights for regulators, payers, and other healthcare decision-makers. 

Ensuring reproducibility of such findings is fundamental to effective evidence-based decision-making.

Read Nature article

Michael Wonder

Posted by:

Michael Wonder